103 related articles for article (PubMed ID: 2884239)
1. Amantadine in the treatment of neuroendocrine side effects of neuroleptics.
Correa N; Opler LA; Kay SR; Birmaher B
J Clin Psychopharmacol; 1987 Apr; 7(2):91-5. PubMed ID: 2884239
[TBL] [Abstract][Full Text] [Related]
2. Mania secondary to amantadine treatment of neuroleptic-induced hyperprolactinemia.
Rego MD; Giller EL
J Clin Psychiatry; 1989 Apr; 50(4):143-4. PubMed ID: 2564388
[TBL] [Abstract][Full Text] [Related]
3. Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients.
Valevski A; Modai I; Zbarski E; Zemishlany Z; Weizman A
Clin Neuropharmacol; 1998; 21(6):355-7. PubMed ID: 9844793
[TBL] [Abstract][Full Text] [Related]
4. The effect of amantadine on prolactin levels and galactorrhea on neuroleptic-treated patients.
Siever LJ
J Clin Psychopharmacol; 1981 Jan; 1(1):2-7. PubMed ID: 6117579
[TBL] [Abstract][Full Text] [Related]
5. Management of psychotropic-induced hyperprolactinemia.
Marken PA; Haykal RF; Fisher JN
Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
[TBL] [Abstract][Full Text] [Related]
6. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
Keller R; Mongini F
Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
[TBL] [Abstract][Full Text] [Related]
7. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
Smith S
J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
[TBL] [Abstract][Full Text] [Related]
9. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
Holzer L; Eap CB
J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
[TBL] [Abstract][Full Text] [Related]
10. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
McEvoy JP; McCue M; Freter S
Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
12. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
Gioia P; Asnis G
J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
Byerly M; Suppes T; Tran QV; Baker RA
J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
[TBL] [Abstract][Full Text] [Related]
14. Amantadine in the treatment of neuroleptic-induced obesity in rats: behavioral, endocrine and neurochemical correlates.
Baptista T; López ME; Teneud L; Contreras Q; Alastre T; de Quijada M; Araujo de Baptista E; Alternus M; Weiss SR; Musseo E; Páez X; Hernández L
Pharmacopsychiatry; 1997 Mar; 30(2):43-54. PubMed ID: 9131724
[TBL] [Abstract][Full Text] [Related]
15. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D
Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406
[TBL] [Abstract][Full Text] [Related]
16. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis associated with neuroleptic treatment. A case report.
Kartaginer J; Ataya K; Mercado A; Abbasi A
J Reprod Med; 1990 Feb; 35(2):198-202. PubMed ID: 1968102
[TBL] [Abstract][Full Text] [Related]
18. Hormonal side effects in women: typical versus atypical antipsychotic treatment.
Dickson RA; Seeman MV; Corenblum B
J Clin Psychiatry; 2000; 61 Suppl 3():10-5. PubMed ID: 10724128
[TBL] [Abstract][Full Text] [Related]
19. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
Nakajima M; Terao T; Iwata N; Nakamura J
Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
[TBL] [Abstract][Full Text] [Related]
20. [Antipsychotic-induced symptomatic hyperprolactinemia: clinical consequences and therapeutic strategies].
Pollice R; Di Giovambattista E; Tomassini A; Di Pucchio A; Ussorio D; Roncone R; Casacchia M
Clin Ter; 2007; 158(2):173-9. PubMed ID: 17566521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
